Back

The association of non-alcoholic fatty liver disease and advanced hepatic fibrosis with cardiovascular mortality in Taiwanese adults: a longitudinal cohort study

25 August 2023 (08:15 - 08:50)
Organised by: Logo
Congress Presentation Part of: Risk factors and prevention: epidemiology (1) Epidemiology ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Ms Xianglin Wei

The Chinese University of Hong Kong, Hong Kong (China)

5 More presentations in this session

Presentation thumbnail
Early lowering of LDL-C is a more cost-effective strategy than lowering LDL-C later in life: a cost-effectiveness analysis using Mendelian Randomisation
Associate Professor Z. Ademi (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Social, behavioral, and metabolic risk factors for racial disparities in cardiovascular disease mortality in US adults
Professor J. He (New Orleans, US)
Abstract Slides Video
Presentation thumbnail
Kidney function and future risk of atherosclerotic cardiovascular disease: a study from, approximately half million adults
Doctor J. Rana (Oakland, US)
Abstract Slides Video
Presentation thumbnail
J-shaped association between serum uric acid levels and chronic kidney disease: a cross-sectional study using large health examination data
Doctor S. Kawasoe (Kagoshima, JP)
Abstract Slides Video
Presentation thumbnail
The impact of longitudinal changes in BMI and serum uric acid levels on new-onset atrial fibrillation
Doctor J. Munakata (Kyoto, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors and prevention: epidemiology (1)

The Event

Event poster

ESC Congress 2023

25 August 2023 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of SGLT2 inhibitors on liver-related outcomes in patients with heart failure - a population-based study in HK
thumbnail
Congress Presentation
Cardiovascular-kidney-liver-metabolic-health:a population-based study on the prognostic impact of the coexistence of metabolic dysfunction-associated steatotic liver disease and chronic kidney disease
thumbnail
Congress Presentation
Predictability of noninvasive liver fibrosis score for cardiac events in patients with nonalcoholic fatty liver disease

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources